1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
TRex Bio Inc.

TRex Bio Inc.

TRXB
TRex Bio Inc.US flagNASDAQ
14.01
USD
-0.15
- -
116.70MMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

Company Profile APIChatGPT
CEO
Marion Johnston Erwin
Full Time Employees
60
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Address
269 E. Grand Ave., Suite 300 South San Francisco CA United States of America 94080
IPO Date
Oct 9, 2026
CIK
0002139097
Website
trex.bio
Similar Companies
Makers Laboratories Limited (MAKERSL.BO)
COSMOS Pharmaceutical Corporation (CSMYF)
Kusuri No Aoki Holdings Co., Ltd. (3549.T)
Trident Lifeline Limited (TLL.BO)
Easywell Biomedicals, Inc. (1799.TWO)
Cawachi Limited (2664.T)
Business
Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil Daud, Wilson Liao, Diane Mathis, Drew Pardoll, Michael Rosenblum, Alison Simmons, and Jim Wells in May 24, 2018 and is headquartered in South San Francisco, CA.

Company News

Company News APIChatGPT